Skip to Content

Join the 'HIV Infection' group to help and get support from people like you.

HIV Infection News

Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS

More Could Benefit from HIV Prevention Pill Truvada

Posted 16 hours ago by

TUESDAY, Nov. 24, 2015 – Too few Americans who are at risk for HIV infection are taking Truvada – a daily pill that could protect them against the virus that causes AIDS, federal health officials report. Health care providers must help boost patient awareness and use of the drug, health experts stressed. About 25 percent of sexually active gay and bisexual adult men, 20 percent of injection drug users, and less than 1 percent of sexually active heterosexuals are at high risk for HIV infection, according to the U.S. Centers for Disease Control and Prevention's Vital Signs report. People in these groups need to know about Truvada, which is also known as the pre-exposure prophylaxis (PrEP) pill, the government experts said. Taken daily, the PrEP pill can reduce the risk of sexually acquired HIV by more than 90 percent. The PrEP pill can reduce injection drug users' risk of HIV by more ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Truvada

Charlie Sheen: I'm HIV-Positive

Posted 8 days ago by

TUESDAY, Nov. 17, 2015 – Actor Charlie Sheen acknowledged Tuesday that he is infected with HIV, the virus that causes AIDS. "It's a hard three letters to absorb. It's a turning point in one's life," Sheen, who is 50, said during an interview on NBC's Today show with co-host Matt Lauer. Sheen said he was diagnosed about four years ago and was going public now for two reasons: to end an extortion campaign that he claimed has cost him millions of dollars and to help combat the stigma of HIV. "I have to put a stop to this onslaught, this barrage of attacks and of sub-truths and very harmful and mercurial stories that are about me, threatening the health of so many others that couldn't be further from the truth," he said of the extortion efforts. Sheen said he initially shared the diagnosis with people he thought he could trust, but has since paid out roughly $10 million to keep his ... Read more

Related support groups: HIV Infection, Incivek, Pre-Exposure Prophylaxis, Baraclude, Victrelis, Tenofovir, Kaletra, Norvir, Entecavir, Viread, Telaprevir, Lamivudine, Reyataz, Efavirenz, Nevirapine, Boceprevir, Hepsera, Prezista, Abacavir, Ritonavir

Reports Say Charlie Sheen HIV-Positive

Posted 9 days ago by

MONDAY, Nov. 16, 2015 – Actor Charlie Sheen is reportedly HIV-positive and will discuss the diagnosis Tuesday morning on NBC's Today show, according to multiple published reports. People magazine reported Monday afternoon that individuals close to Sheen approached Hollywood publicist and crisis manager Howard Bragman six months ago on ways to deal with the matter, but Bragman said he never dealt directly with Sheen. "The interview could open up a lot of sympathy for him, but he has to be concerned about a fear of litigation from former sexual partners. You don't take that lightly," Bragman told the magazine. He added that the 50-year-old Sheen "is getting treatment, and a lot of people in his life know about it." Sheen has a history of substance abuse and has admitted to soliciting prostitutes in the past, People reported. "It's been going on for quite a while. He's not necessarily ... Read more

Related support groups: HIV Infection, Incivek, Pre-Exposure Prophylaxis, Baraclude, Victrelis, Tenofovir, Kaletra, Norvir, Entecavir, Viread, Telaprevir, Lamivudine, Reyataz, Efavirenz, Nevirapine, Boceprevir, Hepsera, Prezista, Abacavir, Ritonavir

Preventive HIV Treatment Shown Effective at Health Clinics

Posted 9 days ago by

MONDAY, Nov. 16, 2015 – Medications taken to prevent HIV infection in high-risk people appear to work well in "real-life" use, a new study suggests. During a year of taking pre-exposure prophylaxis (PrEP), only two people out of more than 400 high-risk people became infected with HIV, the virus that causes AIDS. And it seems that those who became infected didn't take the medication properly, the study said. The new study found the HIV infection rate was as much as 20 times lower than in several previous HIV studies, background information in the current study said. Gay and bisexual men at high risk for HIV infection "should be counseled about pre-exposure prophylaxis," said Dr. Kenneth Mayer, director of HIV Prevention Research at Beth Israel Deaconess Medical Center in Boston, who's familiar with the study findings. Already, he said, "pharmacy records suggest that tens of thousands ... Read more

Related support groups: HIV Infection, Atripla, Pre-Exposure Prophylaxis, Truvada, Stribild, Complera, Tenofovir, Viread, Efavirenz/Emtricitabine/Tenofovir, Emtricitabine/nelfinavir/tenofovir, Emtricitabine/Tenofovir, Emtricitabine/lopinavir/ritonavir/tenofovir, Emtricitabine/rilpivirine/tenofovir, Cobicistat/elvitegravir/emtricitabine/tenofovir

Race Gap in Life Expectancy Is Narrowing: U.S. Study

Posted 19 days ago by

FRIDAY, Nov. 6, 2015 – Black Americans are catching up to whites in life expectancy – largely due to declining rates of death from heart disease, cancer and HIV, a new federal government study finds. Researchers said the study can only show what the trend is, and not the reasons for it. But it's likely that better access to medical treatments has played a role, they added. Americans' life expectancy at birth has risen steadily over the last century, reaching an all-time high of 79 years in 2013. The life expectancy for black people, however, has always lagged behind that of whites, according to the researchers. That gap still exists. But it is narrowing – shrinking from a six-year difference in 1999 to a less than four-year difference in 2013, the study found. And it appears that blacks are living longer because their death rates from heart disease, cancer, HIV and accidents are ... Read more

Related support groups: Cancer, Heart Disease, HIV Infection

FDA Approves Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) for HIV

Posted 19 days ago by

The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. The CDC estimates that 1.2 million persons ages 13 years and older are living with HIV infection, and that more than another 150,000 persons in this age range have HIV but are unaware of their infection. Over the past decade, the number of people living with HIV has increased, while the annual number of new HIV infections has remained relatively stable. “Today’s approval of a fixed dose combination containing a new form of tenofovir provides another effective, once daily complete regimen for patients with HIV-1 infection,” said Edward Cox, M.D., director of the Office of Antimicrobial Products in th ... Read more

Related support groups: HIV Infection, Stribild, Tenofovir, Viread, Cobicistat, Vitekta, Emtricitabine, Cobicistat/elvitegravir/emtricitabine/tenofovir Alafenamide, Cobicistat/elvitegravir/emtricitabine/tenofovir, Elvitegravir, Emtriva, Tybost, Genvoya

Tapeworm May Have Spread Cancer Cells to Colombian Man

Posted 4 Nov 2015 by

WEDNESDAY, Nov. 4, 2015 – Cancer cells transmitted from a common tapeworm appear to have caused cancer-like tumors in a Colombian man with HIV – the first known case of what's called "malignant transformation," U.S. health officials are reporting. The parasite – known as Hymenolepis nana, or the dwarf tapeworm – is the most common human tapeworm worldwide, particularly in developing nations. At any given time, up to 75 million people carry it, according to the U.S. Centers for Disease Control and Prevention. People can become infected with dwarf tapeworm eggs when they eat food contaminated with mouse droppings or insects, or ingest fecal matter from people carrying the parasite. Usually, the invasion causes no symptoms, but in some people, the dwarf tapeworm can continue to reproduce itself in the intestines, according to the case report. In the case of the man with HIV, CDC ... Read more

Related support groups: Cancer, HIV Infection, Lung Cancer, Diagnosis and Investigation, Hymenolepis nana (Dwarf Tapeworm), Computed Tomography

Churches a Good Place for HIV Testing, Treatment in Africa

Posted 13 Oct 2015 by

TUESDAY, Oct. 13, 2015 – Churches and other faith-based centers are good locations to offer HIV testing and treatment for pregnant women in isolated areas of sub-Saharan Africa, a new study shows. Worldwide, about 87 percent of pregnant women with HIV and more than 90 percent of children with HIV live in sub-Saharan Africa, according to UNAIDS, a United Nations health care program that targets HIV and AIDS. Researchers found that pregnant women in hard-to-reach and rural areas of Nigeria who were offered prenatal screening for diseases such as HIV, malaria and syphilis at a monthly church-run baby shower (part of a program called the Healthy Beginning Initiative) were 11 times more likely to get tested for HIV than those who were encouraged to get routine HIV testing at local health facilities. The study was published Oct. 14 in the The Lancet Global Health. Even though simple, ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Reduction of Perinatal Transmission of HIV

HIV Therapy May Also Lower Risk for Hepatitis B, Study Says

Posted 12 Oct 2015 by

MONDAY, Oct. 12, 2015 – Not only does effective HIV therapy thwart the AIDS-causing virus, it may also reduce the risk for hepatitis B infection, a new study says. "What this means to us is that effective HIV therapy appears to restore an impairment in the immune response that protects someone with HIV from acquiring hepatitis B infection," study senior author Dr. Chloe Thio, a professor of medicine at Johns Hopkins University School of Medicine, said in a university news release. The study, published in the October issue of Annals of Internal Medicine, involved 2,400 gay and bisexual men who were enrolled in the Multicenter AIDS Cohort Study. Researchers found that the men successfully treated with HIV therapy had the same risk for hepatitis B infection as the men who did not have HIV. Hepatitis B is a virus that can damage the liver. The study showed HIV-positive men on HIV therapy ... Read more

Related support groups: Harvoni, HIV Infection, Valtrex, Acyclovir, Atripla, Hepatitis B, Ribavirin, Sovaldi, Valacyclovir, Incivek, Pre-Exposure Prophylaxis, Zovirax, Pegasys, Truvada, Stribild, Baraclude, Victrelis, Famciclovir, Complera, Triumeq

Low-Income HIV Patients May Be Doing Better on Obamacare

Posted 8 Oct 2015 by

THURSDAY, Oct. 8, 2015 – Low-income HIV patients who enrolled in Obamacare may be faring better than they did on traditional state assistance, a new study suggests. At least that's the case in Virginia, where the study was done. Researchers found that people infected with HIV (the virus that causes AIDS) who switched from the state's drug-assistance program to an Obamacare insurance plan had greater odds of gaining better control of the disease. Those who enrolled in a plan in 2014 were more likely to get their HIV "viral load" down to very low or undetectable levels in the blood, the study found. "That's the most exciting finding from this study," said lead researcher Dr. Kathleen McManus, a fellow at the University of Virginia School of Medicine, in Charlottesville, Va. "When patients achieve viral load suppression, they're healthier and they're less likely to pass the virus on to ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis

As HIV Patients Live Longer, Certain Cancer Risks Rise: Study

Posted 5 Oct 2015 by

MONDAY, Oct. 5, 2015 – Antiretroviral therapy has extended the lives of people with HIV, but living longer may increase these patients' risk for certain cancers. A study of nearly 90,000 HIV patients revealed a rise in three types of cancer as the AIDS-causing virus has evolved from a probable death sentence into a manageable chronic condition. "We found that the risk of some cancers, such as anal, colorectal and liver cancers, are increasing over time mainly because HIV patients are living longer," said study lead author Michael Silverberg, of the Kaiser Permanente division of research in Oakland, Calif. Kaiser Permanente is one of the nation's largest health plans. According to the U.S. National Cancer Institute, HIV patients have always faced a significantly higher cancer risk, most notably for Kaposi sarcoma, non-Hodgkin lymphoma and cervical cancer. That's because of a generally ... Read more

Related support groups: Cancer, HIV Infection, Colorectal Cancer, Cervical Cancer, Solid Tumors

Almost Half of American Adults With HIV Don't Take Meds: Report

Posted 24 Sep 2015 by

THURSDAY, Sept. 24, 2015 – Almost half of American adults infected with HIV don't take medications that can prevent them from developing AIDS, a new government report shows. The statistics, based on data gathered from 2007 to 2012, are a few years out of date, so it's not clear whether the situation has changed. Still, the report – an analysis of people aged 18 to 59 – suggests a widespread lack of recommended care. "Based on what we know nowadays, everyone who's HIV-positive should be on therapy," said Dr. Carlos del Rio, co-director of the Center for AIDS Research at Emory University, in Atlanta. "This highlights the challenges we have ahead because we have such an unequal epidemic." The report, authored by Dr. Joseph Woodring of the U.S. National Center for Health Statistics, estimated the prevalence of HIV infection based on a survey of more than 10,000 people. The survey found ... Read more

Related support groups: HIV Infection, Tamiflu, Sovaldi, Incivek, Pre-Exposure Prophylaxis, Baraclude, Victrelis, Tenofovir, Kaletra, Sofosbuvir, Oseltamivir, Norvir, Viread, Entecavir, Telaprevir, Lamivudine, Boceprevir, Efavirenz, Reyataz, Nevirapine

More Evidence Daily Pill Can Prevent HIV Transmission

Posted 10 Sep 2015 by

WEDNESDAY, Sept. 9, 2015 – There's more data showing that a daily HIV medication called Truvada may prevent HIV-negative gay men at high-risk for infection from contracting the AIDS-causing virus. The treatment, known as pre-exposure prophylaxis (PrEP), is very effective at preventing new HIV infections and should be added to the HIV prevention toolkit for gay men at risk of HIV infection, British researchers reported in the Sept. 9 issue of The Lancet. Previous studies have shown that Truvada (tenofovir-emtricitabine) can reduce the risk of HIV infection. But it was unclear if the benefits of this preventive treatment would be offset by an increase in risky behavior among those who believed the medication protected them from the virus, the study authors explained in a journal news release. A team of researchers led by Sheena McCormack, of the Medical Research Council clinical trials ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Truvada

Needle-Exchange Program Curbed HIV Spread, Study Finds

Posted 3 Sep 2015 by

THURSDAY, Sept. 3, 2015 – A needle-exchange program in Washington, D.C., has prevented hundreds of new HIV infections, a new study suggests. The program for injection drug users was launched in 2007, and it prevented an estimated 120 new cases of HIV infection and saved about $44 million in HIV treatment costs within two years, the researchers said. The findings were published online Sept. 3 in the journal AIDS and Behavior. "Our study adds to the evidence that needle-exchange programs not only work, but are cost-effective investments in the battle against HIV," Monica Ruiz, of George Washington University in Washington, D.C., said in a university news release. Ruiz is an assistant research professor in the department of prevention and community health at the university's Milken Institute School of Public Health. "We saw a 70 percent drop in newly diagnosed HIV cases in just two years. ... Read more

Related support groups: HIV Infection

Gains in Life Spans Seen Around the Globe

Posted 27 Aug 2015 by

THURSDAY, Aug. 27, 2015 – Average life expectancy among people worldwide has risen by more than six years since 1990, and healthy life expectancy has climbed by more than five years, a new report shows. The analysis of data from 188 countries found that life expectancy for both sexes increased from just over 65 years in 1990 to 71.5 years in 2013, while healthy life expectancy rose from almost 57 years to slightly more than 62 years. The findings regarding healthy life expectancy versus total life expectancy mean that people are living more years with illness and disability, according to the authors of the study published Aug. 27 in The Lancet. "The world has made great progress in health, but now the challenge is to invest in finding more effective ways of preventing or treating the major causes of illness and disability," study author Theo Vos, a professor at the Institute for Health ... Read more

Related support groups: Diabetes, Type 2, Back Pain, Heart Disease, Chronic Obstructive Pulmonary Disease, Ischemic Stroke, HIV Infection, Malaria, Respiratory Tract Disease, Ischemic Heart Disease

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Pre-Exposure Prophylaxis, Viral Infection

Related Drug Support Groups

Atripla, Truvada, Stribild, Complera, Triumeq, tenofovir, Kaletra, Norvir, Viread, view more... lamivudine, nevirapine, efavirenz, Reyataz, Lexiva, Norvir Soft Gelatin, abacavir, ritonavir, Combivir, Prezista, Epivir, indinavir, Sustiva, Trizivir, Agenerase, Privigen, immune globulin intravenous, dolutegravir, Tivicay, Sandoglobulin, didanosine, Ziagen, Carimune, Octagam, Telzir, abacavir / dolutegravir / lamivudine, stavudine, darunavir, Retrovir, atazanavir, amprenavir, Epzicom, lamivudine / zidovudine, nelfinavir, zidovudine, Fuzeon, Isentress, Edurant, raltegravir, Gammar-P IV, Selzentry, Gammagard S / D, Venoglobulin-S 5%, Venoglobulin-S 10%, Carimune NF, Vitekta, Viramune XR, Gammar IV, Tybost, Evotaz, Genvoya, Dutrebis, Prezcobix, Gammaplex, Intelence, Panglobulin, Gamimune N 10%, Gamimune N 5%, Iveegam En, Zerit XR, Gamimune, Panglobulin NF, Polygam S / D, Crixivan, zalcitabine, tipranavir, saquinavir, etravirine, emtricitabine / lopinavir / ritonavir / tenofovir, emtricitabine / rilpivirine / tenofovir, rilpivirine, emtricitabine / nelfinavir / tenofovir, maraviroc, lopinavir / ritonavir, delavirdine, abacavir / lamivudine / zidovudine, abacavir / lamivudine, efavirenz / emtricitabine / tenofovir, emtricitabine, fosamprenavir, enfuvirtide, emtricitabine / tenofovir, cobicistat / elvitegravir / emtricitabine / tenofovir, elvitegravir, Viramune, Viracept, Epivir-HBV, Fortovase, Invirase, Hivid, Aptivus, Zerit, Emtriva, Videx EC, cobicistat / darunavir, atazanavir / cobicistat, cobicistat, lamivudine / raltegravir, cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide, Videx, Rescriptor, Flebogamma